Venous thromboembolism (VTE), consisting of deep vein thrombosis and pulmonary
embolism, is a major clinical concern associated with significant morbidity and mortality. The …

Interventions: Intravenous antibiotics along with anticoagulants and laparoscopic
appendectomy Outcomes: After 1 month, a follow-up ultrasonography revealed full …

Background At the present, apixaban is the only nonvitamin K oral anticoagulant approved
by the Food and Drug Administration for use with patients with creatinine clearance< 15 …

Background: Apixaban is an oral, potent, highly selective, reversible and direct inhibitor of
activated coagulation factor X, that is the end point of the intrinsic and extrinsic coagulation …

As a result of the aging US population and the subsequent increase in the prevalence of
coronary disease and atrial fibrillation, therapeutic use of anticoagulants has increased …

Direct oral anticoagulants (DOACs) are being increasingly used in the clinical setting for
patients at risk of venous thromboembolism (VTE) and/or stroke. These medications offer …

Methods: The PearlDiver MHip national database was queried for patients older than 60
years undergoing first-time hip fracture surgery with no concurrent pelvic or distal femoral …

A 35-year-old male patient with lepromatous leprosy came to the emergency room (ER) due
to breathlessness and chest pain. The patient was diagnosed with pulmonary tuberculosis …

Deep Vein Thrombosis (DVT) has been known as a common medical problem all over the
world. Thrombus traveling in blood vessels may lead to pulmonary embolism (PE) …

Objective. The aim of this study was to explore the clinical efficacy of conventional heparin
anticoagulation in combination with apixaban in the treatment of patients with cerebral …